June 18, 2024
CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
SOUTH SAN FRANCISCO, Calif., June 17, 2024 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
June 18, 2024
GENFIT: New EASL-EASD-EASO Clinical Practice Guidelines for MASLD Include NIS2+® as Key Tool for Detecting At-Risk MASH
Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), June 17, 2024 – GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical…
June 18, 2024
Telomir Pharmaceuticals Scientific Advisor to Participate in Drug Information Association 2024 Global Annual Meeting Panel
Drug Information Association (DIA) 2024 is the largest global, multidisciplinary event for the professionals involved in the discovery, development, and…
June 18, 2024
Bionano Laboratories Announces New Category I CPT Code for OGM Use in Hematological Malignancy Analysis
SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) — Bionano Laboratories, a clinical laboratory services business of Bionano Genomics, Inc. (Nasdaq:…
June 18, 2024
Oncocyte Appoints Andrea James as Chief Financial Officer
IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it…
June 18, 2024
SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States
Further Advances SIGA’s Strategy to Expand Access to TPOXX into More International MarketsNEW YORK, June 17, 2024 (GLOBE NEWSWIRE) —…
June 17, 2024
Heinlein Plastik-Technik becomes a member of the ALPLA Group
The ALPLA Group is further expanding its pharma division ALPLApharma with its acquisition of Heinlein Plastik-Technik GmbH.
June 17, 2024
Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
Ian Taylor, Ph.D. President of Research and Development at Arvinas, Inc. Angela Cacace, Ph.D. Chief Scientific Officer at Arvinas, Inc.…
June 17, 2024
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., June 17, 2024 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing…
June 17, 2024
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics Launch Video With a mission to redefine what gene therapy can do, Spur is optimizing every component of…